KYNDALL DENNEY: Open Payments
NPI 1104530740 · LEESBURG, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 30 payments from 12 companies in 2025. Trend: 2023 $358 · 2024 $814 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $84 |
| Amgen Inc. | 3 | $44 |
| ViiV Healthcare Company | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $24 |
| PFIZER INC. | 1 | $22 |
Products named: Kerendia, Ozempic, Wegovy, OTEZLA, DOVATO, AIRSUPRA, GEMTESA, REXULTI.
Industry payments across GA — which companies pay providers there.
